CompoAtlas

PERTRES

Natural health product licensed in Canada

Licence holder
NUTRITION NATURHOUSE Inc.
NPN or DIN-HM
80119800
Status
Active licence
Licence date
7 July 2022
Revision date
Not provided
Form
Liquide oral, solution
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Passiflora incarnata

Source : Passiflora incarnata - Herb top

Extract : Matériel brut frais

462 mgNot calculated

Non-medicinal ingredients

Eau, D-Fructose, Extrait de fruits de Rosa canina, Extrait de fleurs de tilleul, Extrait de verveine citronelle (Lippia Citriodora), Acide citrique monohydraté, Feuilles séchées de mélisse, Écorce d' Oranger Amer, Extrait de fruit d'Anis, Sorbate de potassium, Gomme de xanthane, Miel

PopulationAgeQuantity per servingFrequency
AdultesNot specified10 mL2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

(Traditionally) used in Herbal Medicine as a sleep aid (during times of mental stress). (Traditionally) used in Herbal Medicine to help relieve restlessness and/or nervousness (calmative).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80119800

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line